Role of Mesenchymal Stem/Stromal Cells (MSCs) and MSC-Derived Extracellular Vesicles (EVs) in Prevention of Telomere Length Shortening, Cellular Senescence, and Accelerated Biological Aging
Authors:
- Myrna Y. Gonzalez ArellanoMAMyrna Y. Gonzalez Arellano
- Matthew VanHeestMVMatthew VanHeest
- Sravya EmmadiSESravya Emmadi
- Amal Abdul-HafezAAAmal Abdul-Hafez
- Sherif Abdelfattah IbrahimSherif Abdelfattah Ibrahim
- Ranga P. ThiruvenkataramaniRTRanga P. Thiruvenkataramani
- Rasha S. TelebRTRasha S. Teleb
- Hady OmarHOHady Omar
- Tulasi KesarajuTKTulasi Kesaraju
- Tarek MohamedTMTarek Mohamed
- Burra V. MadhukarBMBurra V. Madhukar
- Said A. OmarSOSaid A. Omar
Open Access
- 21 May 2024
- journal article
- review article
- Published by MDPI AG in Bioengineering
- Vol. 11 (6) , 524
Abstract
Biological aging is defined as a progressive decline in tissue function that eventually results in cell death. Accelerated biologic aging results when the telomere length is shortened prematurely secondary to damage from biological or environmental stressors, leading to a defective reparative mechanism. Stem cells therapy may have a potential role in influencing (counteract/ameliorate) biological aging and maintaining the function of the organism. Mesenchymal stem cells, also called mesenchymal stromal cells (MSCs) are multipotent stem cells of mesodermal origin that can differentiate into other types of cells, such as adipocytes, chondrocytes, and osteocytes. MSCs influence resident cells through the secretion of paracrine bioactive components such as cytokines and extracellular vesicles (EVs). This review examines the changes in telomere length, cellular senescence, and normal biological age, as well as the factors contributing to telomere shortening and accelerated biological aging. The role of MSCs—especially those derived from gestational tissues—in prevention of telomere shortening (TS) and accelerated biological aging is explored. In addition, the strategies to prevent MSC senescence and improve the antiaging therapeutic application of MSCs and MSC-derived EVs in influencing telomere length and cellular senescence are reviewed.Keywords
This publication has 128 references indexed in Scilit:
- Repeated Injury Promotes Tracheobronchial Tissue Stem Cell AttritionStem Cells Translational Medicine, 2021
- Understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applicationsStem Cells, 2019
- Mitochondrial dysfunction and cell senescence: deciphering a complex relationshipFEBS Letters, 2019
- Abrogation of Age-Induced MicroRNA-195 Rejuvenates the Senescent Mesenchymal Stem Cells by Reactivating TelomeraseStem Cells, 2015
- Cell Senescence Abrogates the Therapeutic Potential of Human Mesenchymal Stem Cells in the Lethal Endotoxemia ModelStem Cells, 2014
- Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney TransplantsJAMA, 2012
- Isolation and characterization of mesenchymal cells from human fetal membranesJournal of Tissue Engineering and Regenerative Medicine, 2007
- Stem Cells: An OverviewCurrent Protocols in Cell Biology, 2005
- Asp-Ala-His-Lys (DAHK) Inhibits Copper-Induced Oxidative DNA Double Strand Breaks and Telomere ShorteningBiochemical and Biophysical Research Communications, 2001
- Mild Hyperoxia Shortens Telomeres and Inhibits Proliferation of Fibroblasts: A Model for Senescence?Experimental Cell Research, 1995